Biểu đồ giá cổ phiếu ACRV
ACRV Giá
Acrivon Therapeutics Inc
$1.98
-2.46%
$-0.04
Khi đóng cửa: May 08, 16:00:00 GMT-4
$1.95
-1.51%
$-0.03
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
Acrivon Therapeutics Inc (ACRV) Giá
Thống kê chính
Giá đóng cửa trước
$2.03
Giá mở cửa
$2.04
Phạm vi ngày
$1.95 - $2.08
Phạm vi 52 tuần
$1.05 - $3.56
Khối lượng
540.5K
Khối lượng trung bình
1.4M
Tỷ suất cổ tức
--
EPS (TTM)
-2.23
Vốn hóa thị trường
$75.5M
ACRV là gì?
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. The company is headquartered in Watertown, Massachusetts and currently employs 74 full-time employees. The company went IPO on 2022-11-15. The company uses its precision Generative Phosphoproteomics platform, Acrivon Predictive Precision Proteomics (AP3), to develop its pipeline of oncology drug candidates. Its lead candidate, ACR-368, is a selective small molecule inhibitor which targets CHK1 and CHK2 at sub single-digit nM and single-digit nM potency in intact cells, respectively, in a registrational Phase II trial across multiple solid tumor types. Using its AP3 platform, it has developed a predictive OncoSignature test for ACR-368, called ACR-368 OncoSignature, that can predict patient response to ACR-368 monotherapy and therefore improve the clinical overall response rate (ORR) and has the potential to enable drug development. Its preclinical program, ACR-2316, is advancing in investigational new drug-enabling studies. The company is a novel, dual WEE1 and PKMYT1 inhibitor small molecule development candidate.
